Latest Commercialisation News

Imricor Medical Systems has officially launched its US commercial operations, securing Rady Children’s Hospital–San Diego as the first customer for its NorthStar iMR mapping system, following key FDA clearances including pediatric approvals.

Patrys Limited is pushing forward with a proprietary injectable formulation of quetiapine targeting the lucrative delirium treatment market, leveraging a faster, lower-cost FDA 505(b)(2) regulatory pathway and strong patent protection.

Zeotech completed a 110-hole drilling campaign at Toondoon, secured key approvals, progressed AusPozz™ commercial trials, and demonstrated a 92% methane reduction in landfill trials.

I Synergy Group has appointed Anson Heng as Executive Chairman and Managing Director to spearhead its strategic cooperation with Macau Direch, formalised through a non-binding MoU targeting blockchain, AI, and digital asset initiatives.

Latrobe Magnesium (ASX: LMG) is set for leadership change with Robert Stein stepping in as CEO from October 2026, while Peter Mizera takes charge of the Construction Committee, underpinning the company’s push towards magnesium metal production.

Atomo Diagnostics reported a 40% increase in FY26 revenue to $5.3 million, driven by a surge in HIV self-test sales and new OEM customer orders. The company is advancing its syphilis and liver test developments while enhancing manufacturing capacity.

Adisyn has confirmed a repeatable, industrial-scale graphene deposition process compatible with semiconductor manufacturing temperatures, while advancing exclusive radar absorption technology for drones with major partners.

Australian Rare Earths (ASX: AR3) has uncovered a 10-kilometre magnetic anomaly at its Overland Project, significantly broadening its niobium-rare earth element drill targets beyond the initial OV167 discovery. Historic drill data supports the potential for a large-scale carbonatite system, prompting a new drilling campaign to test multiple priority targets.

Green360 Technologies has locked in its inaugural commercial supply contract with Holcim Australia for up to 4,800 tonnes of its MKX-CC low-carbon cement replacement, marking its shift from development to commercial sales amid tightening supplementary cementitious material supplies.

Artrya has launched its AI-powered Salix platform at Northeast Georgia Health System, marking its second U.S. commercial customer with active revenue streams from subscription and fee-per-scan models.

Ore Resources (ASX: OR3) reported substantial drilling success in lithium and gold at its Coolgardie projects, confirming extensions at Kangaroo Hills lithium pegmatites and Forrest gold system, while expanding landholdings and advancing development studies.

Papyrus Australia has tapped related party L39 Capital to lead a capital raise and secured an interest-bearing $200,000 loan from Irwin Biotech, with conversion into shares and options pending shareholder approval.